Canopy Growth (CGC)
(Delayed Data from NSDQ)
$4.86 USD
+0.27 (5.88%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.86 USD
+0.27 (5.88%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Zacks News
Homology Medicines (FIXX) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Homology Medicines (FIXX) delivered earnings and revenue surprises of 20% and 38.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Apyx (APYX) delivered earnings and revenue surprises of -30.77% and 7.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $5.44, moving -1.98% from the previous trading session.
3 Medical Product Stocks Set to Beat on Earnings This Season
by Trina Mukherjee
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how CGC, HAE and ALC are poised ahead of their earnings releases.
Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $6.06 in the latest trading session, marking a +0.17% move from the prior day.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $5.23, marking a -1.32% move from the previous day.
Canopy Growth Corporation (CGC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $5.75 in the latest trading session, marking a +0.35% move from the prior day.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $5.93 in the latest trading session, marking a -1% move from the prior day.
US Stocks Float Higher Ahead Of Q1 Earnings Season
by Daniel Laboe
Market undertones are turning from a mere buy-the-dip rally to demonstrating real breakout internals
3 Winning ETF Areas of Last Week (Revised)
by Sanghamitra Saha
Along with rising rate worries, growing tensions between Russia and Ukraine weighed on the global markets last week.
3 Winning ETF Areas of Last Week
by Sanghamitra Saha
Along with rising rate worries, growing tensions between Russia and Ukraine weighed on the global markets last week.
5 Best Leveraged ETFs of Last Week Up At Least 10%
by Sanghamitra Saha
Wall Street was mixed-to-downbeat last week. A new 40-year high inflation reading and rising rate worries played spoilsport.
Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of 4.35% and 1.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Canopy Growth (CGC) in Q3 Earnings?
by Zacks Equity Research
New product launches across the CBD product portfolio and robust demand for legal cannabis products are likely to drive Canopy Growth's (CGC) Q3 top line.
Will Canopy Growth Corporation (CGC) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $7.40, marking a +1.51% move from the previous day.
Canopy Growth Corporation (CGC) Stock Moves -1.05%: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $7.56 in the latest trading session, marking a -1.05% move from the prior day.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $8.40, marking a -0.12% move from the previous day.
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $8.21, moving -1.91% from the previous trading session.
Ulta Beauty and Freshpet have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Ulta Beauty and Freshpet have been highlighted as Zacks Bull and Bear of the Day
Ride The Cannabis Legalization Wave With These 3 Stocks
by Tirthankar Chakraborty
Stocks like Cronos Group (CRON), Canopy Growth (CGC) and Innovative Industrial Properties (IIPR) are sure to benefit at present amid the cannabis legalization wave.
Do Options Traders Know Something About Canopy Growth (CGC) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to for Canopy Growth (CGC) stock based on the movements in the options market lately.
Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $9.27 in the latest trading session, marking a +1.31% move from the prior day.
Should You Buy Beaten Down Cannabis Stocks & ETFs Now?
by Neena Mishra
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -178.57% and -6.23%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?